Evidence map›Paper›PMID 40289852›Full record

ArticleAnnals of laboratory medicine2025

Kyoung Ho Roh, Nguyen Dinh Luong, Changseung Liu, Young Hee Seo, Hyukmin Lee, Magnus Unemo, Kyungwon Lee

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of laboratory medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. In Vitro Activity of Zoliflodacin AgainstAntibiotics (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kyoung Ho RohDepartment of Laboratory Medicine, National Health Insurance Ilsan Hospital, Goyang, Korea.ORCID https://orcid.org/0000-0002-6291-9229
Nguyen Dinh LuongPasteur Institute in Nha Trang, Nha Trang, Vietnam.ORCID https://orcid.org/0000-0001-6827-2430
Changseung LiuDepartment of Laboratory Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea.ORCID https://orcid.org/0000-0002-8777-7431
Young Hee SeoDepartment of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-3585-5335
Hyukmin LeeDepartment of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-8523-4126
Magnus UnemoWorld Health Organization Collaborating Centre for Gonorrhoea and other STIs, Örebro University, Örebro, Sweden.ORCID https://orcid.org/0000-0003-1710-2081
Kyungwon LeeDepartment of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-3788-2134

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Novel antimicrobial agents are continually developed to address the global threat of multidrug-resistant

Indexed as

Anti-Bacterial AgentsBarbituratesMacrolidesNaphthyridinesNeisseria gonorrhoeaeTriazolesCeftriaxoneCiprofloxacinDrug Resistance, Multiple, BacterialGonorrheaHumansIsoxazolesMicrobial Sensitivity TestsMorpholinesOxazolidinonesRepublic of KoreaAnti-Bacterial AgentsBarbituratesCeftriaxoneCiprofloxacinIsoxazolesMacrolidesMorpholinesNaphthyridinesOxazolidinonessolithromycinSpiro CompoundsTriazoleszoliflodacinAntimicrobial resistanceAzithromycinCefiximeCeftriaxoneGonorrheaSexually transmitted infectionsSolithromycinSpectinomycinZoliflodacin

Identifiers

PMID40289852
PMCPMC12535836

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.